Search Results 111-120 of 17582 for cannabis

  1. An Open Label Extension Study Of Cannabidiol (GWP42003-P) In Children And Young Adults With Dravet Or Lennox-Gastaut Syndromes - Mayo Clinic

    Patient is unwilling to abstain from using recreational or medicinal cannabis, or synthetic cannabinoid-based medications (including Sativex) during the study.

  2. A Study to Identify and Characterize Neurophysiological Biomarkers for Progression of Neurodegenerative Disease - Mayo Clinic

    History of marijuana/cannabis use (amount/ times per week). Excessive tobacco use (i.e. more than 10 cigarettes a day). Excessive alcohol (> 5 drinks daily ...

  3. Midazolam (nasal route) - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Ceritinib; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone ...

  4. Publications - Sanjay Chaudhary, M.B.B.S. - Mayo Clinic

    Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol. 2009 Mar 14; 15 ...

  5. Publications - Michelle A. Neben Wittich, M.D. - Mayo Clinic

    Medical Cannabis to Treat Symptoms From Head and Neck Radiation Therapy. Pract Radiat Oncol. 2021 Sep-Oct; 11 (5):313-316. View PubMed; Hazim AZ, Reed CT ...

  6. A Study to Evaluate the Therapeutic Effectiveness of Rifaximin in Diabetic Gastroparesis Patients Using Bloating as the Primary Endpoint - Mayo Clinic

    Known mechanical obstruction of the GI tract; current or recent (< 4 weeks) use of opioids; current/active use of cannabis. Current or recent (< 4 weeks) ...

  7. Multiple sclerosis - Diagnosis and treatment - Mayo Clinic

    There is a lack of evidence that cannabis in any other form is effective in managing other MS symptoms. Daily intake of vitamin D3 of 2,000 to 5,000 ...

  8. 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression - Mayo Clinic

    Negative urine toxicology screen (except cannabis). ... History of active substance abuse disorder within the last 3 months (other than caffeine or cannabis) ...

  9. A Study to Evaluate Feasibility of Microburst Vagus Nerve Stimulator (VNS) Therapy - Mayo Clinic

    Currently being treated with prescribed medication that contains cannabis or cannabis related substance. Any history of psychogenic non-epileptic seizures ...

  10. A Study to Compare Episcleral Venous Pressure Measured in Multiple Body Positions with Two Devices - Mayo Clinic

    Use of any products of cannabis (THC or CBD compounds) within the past 30 days. Lack of suitable episcleral vein for EVP measurement. Participating Mayo ...